<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36877677</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>3</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Long COVID-six months of prospective follow-up of changes in symptom profiles of non-hospitalised children and young people after SARS-CoV-2 testing: A national matched cohort study (The CLoCk) study.</ArticleTitle><Pagination><StartPage>e0277704</StartPage><MedlinePgn>e0277704</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0277704</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0277704</ELocationID><Abstract><AbstractText Label="BACKGROUND">Little is known about the prevalence and natural trajectory of post-COVID symptoms in young people, despite very high numbers of young people having acute COVID. To date, there has been no prospective follow-up to establish the pattern of symptoms over a 6-month time period.</AbstractText><AbstractText Label="METHODS">A non-hospitalised, national sample of 3,395 (1,737 SARS-COV-2 Negative;1,658 SARS-COV-2 Positive at baseline) children and young people (CYP) aged 11-17 completed questionnaires 3 and 6 months after PCR-confirmed SARS-CoV-2 infection between January and March 2021 and were compared with age, sex and geographically-matched test-negative CYP.</AbstractText><AbstractText Label="RESULTS">Three months after a positive SARS-CoV-2 PCR test, 11 of the 21 most common symptoms reported by &gt;10% of CYP had reduced. There was a further decline at 6 months. By 3 and 6 months the prevalence of chills, fever, myalgia, cough and sore throat of CYP who tested positive for SARS-CoV-2 reduced from 10-25% at testing to &lt;3%. The prevalence of loss of smell declined from 21% to 5% at 3 months and 4% at 6 months. Prevalence of shortness of breath and tiredness also declined, but at a lower rate. Among test-negatives, the same common symptoms and trends were observed at lower prevalence's. Importantly, in some instances (shortness of breath, tiredness) the overall prevalence of specific individual symptoms at 3 and 6 months was higher than at PCR-testing because these symptoms were reported in new cohorts of CYP who had not reported the specific individual symptom previously.</AbstractText><AbstractText Label="CONCLUSIONS">In CYP, the prevalence of specific symptoms reported at time of PCR-testing declined with time. Similar patterns were observed among test-positives and test-negatives and new symptoms were reported six months post-test for both groups suggesting that symptoms are unlikely to exclusively be a specific consequence of SARS-COV-2 infection. Many CYP experienced unwanted symptoms that warrant investigation and potential intervention.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Stephenson et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stephenson</LastName><ForeName>Terence</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto Pereira</LastName><ForeName>Snehal M</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0002-0876-8757</Identifier><AffiliationInfo><Affiliation>Division of Surgery &amp; Interventional Science, Faculty of Medical Sciences, University College London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nugawela</LastName><ForeName>Manjula D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McOwat</LastName><ForeName>Kelsey</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4170-1498</Identifier><AffiliationInfo><Affiliation>Immunisation Department, UK Health Security Agency, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simmons</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Immunisation Department, UK Health Security Agency, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chalder</LastName><ForeName>Trudie</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ford</LastName><ForeName>Tamsin</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heyman</LastName><ForeName>Isobel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swann</LastName><ForeName>Olivia V</ForeName><Initials>OV</Initials><AffiliationInfo><Affiliation>Centre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fox-Smith</LastName><ForeName>Lana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas</LastName><ForeName>Natalia K</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalrymple</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ladhani</LastName><ForeName>Shamez N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Immunisation Department, UK Health Security Agency, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paediatric Infectious Diseases Research Group, St. George's University of London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shafran</LastName><ForeName>Roz</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UCL Great Ormond Street Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>CLoCk Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/P020372/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063806" MajorTopicYN="N">Myalgia</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Terence Stephenson is Chair of the Health Research Authority and therefore recused himself from the Research Ethics Application. Trudie Chalder is a member of the National Institute for Health and Care Excellence committee for long COVID. She has written self-help books on chronic fatigue and has done workshops on chronic fatigue and post infectious syndromes. All remaining authors have no conflicts of interest. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>6</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36877677</ArticleId><ArticleId IdType="pmc">PMC9987792</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0277704</ArticleId><ArticleId IdType="pii">PONE-D-22-21048</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Molteni E, Sudre CH, Canas LS, Bhopal SS, Hughes RC, Antonelli M, et al.. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. The Lancet Child &amp; Adolescent Health. 2021;5(10):708&#x2013;18. doi: 10.1016/s2352-4642(21)00198-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2352-4642(21)00198-x</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al.. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;31. Epub 2021/03/12. doi: 10.1038/s41591-021-01292-y ; PubMed Central PMCID: PMC7611399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevinsky JR, Tao G, Lavery AM, Kukielka EA, Click ES, Malec D, et al.. Late Conditions Diagnosed 1&#x2013;4 Months Following an Initial Coronavirus Disease 2019 (COVID-19) Encounter: A Matched-Cohort Study Using Inpatient and Outpatient Administrative Data-United States, 1 March-30 June 2020. Clin Infect Dis. 2021;73(Suppl 1):S5&#x2013;S16. doi: 10.1093/cid/ciab338 PubMed Central PMCID: PMC8135331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab338</ArticleId><ArticleId IdType="pmc">PMC8135331</ArticleId><ArticleId IdType="pubmed">33909072</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood SA, Shafran R, Bennett SD, Zhang AXD, O&#x2019;Mahoney LL, Stephenson TJ, et al.. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies. J Infect. 2022;84(2):158&#x2013;70. doi: 10.1016/j.jinf.2021.11.011 ; PubMed Central PMCID: PMC8604800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children&#x2014;a nationwide cohort study. Eur J Pediatr. 2022;181(4):1597&#x2013;607. doi: 10.1007/s00431-021-04345-z ; PubMed Central PMCID: PMC8742700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero Diego KL, Dauvrin Marie, Detollenaere Jens, Maertens de Noordhout Charline, Primus-de Jong C&#xe9;lia, Cleemput Irina, Van den Heede Koen. Long COVID: Pathophysiology&#x2013;epidemiology and patient needs. Brussels.: Belgian Health Care Knowledge Centre (KCE). 2021.  [cited 2022 June 1]. Available from: https://database.inahta.org/article/20213.</Citation></Reference><Reference><Citation>Kikkenborg Berg S, Dam Nielsen S, Nygaard U, Bundgaard H, Palm P, Rotvig C, et al.. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study. The Lancet Child &amp; Adolescent Health. 2022;6(4):240&#x2013;8. doi: 10.1016/S2352-4642(22)00004-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00004-9</ArticleId><ArticleId IdType="pmc">PMC8820960</ArticleId><ArticleId IdType="pubmed">35143771</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson K, Skyrud KD, Suren P, Greve-Isdahl M, St&#xf8;rdal K, Kristoffersen DT, et al.. Healthcare use in 700&#x2009;000 children and adolescents for six months after covid-19: before and after register based cohort study. BMJ. 2022;376:e066809. Epub 2022/01/19. doi: 10.1136/bmj-2021-066809 ; PubMed Central PMCID: PMC8762452 at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-066809</ArticleId><ArticleId IdType="pmc">PMC8762452</ArticleId><ArticleId IdType="pubmed">35039315</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov IM, Spiridonova E, Bobkova P, Gamirova A, Shikhaleva A, Andreeva M, et al.. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J. 2022;59(2). Epub 2021/07/03. doi: 10.1183/13993003.01341-2021 ; PubMed Central PMCID: PMC8576804 unrestricted research grants on the composition of breast milk to Ulm University and Leipzig University with funding from Danone Nutricia Research. M.G. Semple reports grants from the Dept of Health and Social Care National Institute of Health ResearchUK, grants from the Medical Research Council UK, grants from the Health Protection Research Unit in Emerging &amp; Zoonotic Infections, University of Liverpool, outside the submitted work; he also reports a minority ownership at Integrum Scientific LLC (Greensboro, NC, USA), outside the submitted work. T. Vos reports personal fees for work on the Global Burden of Disease Study from the Bill and Melinda Gates Foundation, outside the submitted work. C. Apfelbacher has received lecture fees from AstraZeneca, and is a member of a group developing a core outcome set for long COVID, outside the submitted work. All other authors report no relevant conflict of interests.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Say D, Crawford N, McNab S, Wurzel D, Steer A, Tosif S. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. The Lancet Child &amp; Adolescent Health. 2021;5(6):e22&#x2013;e3. doi: 10.1016/s2352-4642(21)00124-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2352-4642(21)00124-3</ArticleId><ArticleId IdType="pmc">PMC8057863</ArticleId><ArticleId IdType="pubmed">33891880</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Shafran R, De Stavola B, Rojas N, Aiano F, Amin-Chowdhury Z, et al.. Long COVID and the mental and physical health of children and young people: national matched cohort study protocol (the CLoCk study). BMJ Open. 2021;11(8):e052838. Epub 2021/08/28. doi: 10.1136/bmjopen-2021-052838 ; PubMed Central PMCID: PMC8392739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-052838</ArticleId><ArticleId IdType="pmc">PMC8392739</ArticleId><ArticleId IdType="pubmed">34446502</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Pinto Pereira SM, Shafran R, de Stavola BL, Rojas N, McOwat K, et al.. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. The Lancet Child &amp; Adolescent Health. 2022;6(4):230&#x2013;9. doi: 10.1016/s2352-4642(22)00022-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2352-4642(22)00022-0</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L,; Buonsenso D, Dunn, Galvin A, Garralda E, Jones C, Nicholls DE, Swann O, Whittaker EA, Warner JO, Cheung KY, Apfelbacher C, Simpson F, Genuneit J, Dalton H, Holden KA, Brough H, Beeretz I, Bielicki JA, Pollock L, Greenhawt M, Srinivas M, Comberiati P, Peroni D, Scott J, Hamers RL, Semple MG, Kim Y-G, Munblit D. ISARIC Global COVID-19 paediatric follow-up 2021 [cited 2021 November 2]. Available from: https://isaric.org/research/covid-19-clinical-research-resources/paediatric-follow-up/.</Citation></Reference><Reference><Citation>Digital NHS. Mental Health of Children and Young People in England, 2020: Wave 1 follow up to the 2017 survey.
2020 [cited 2021 November 2]. Available from: https://tinyurl.com/NHSWave1FU</Citation></Reference><Reference><Citation>Goodman R. Psychometric properties of the strengths and difficulties questionnaire. J Am Acad Child Adolesc Psychiatry. 2001;40(11):1337&#x2013;45. Epub 2001/11/09. doi: 10.1097/00004583-200111000-00015 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00004583-200111000-00015</ArticleId><ArticleId IdType="pubmed">11699809</ArticleId></ArticleIdList></Reference><Reference><Citation>Tennant R, Hiller L, Fishwick R, Platt S, Joseph S, Weich S, et al.. The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007;5:63. Epub 2007/11/29. doi: 10.1186/1477-7525-5-63 ; PubMed Central PMCID: PMC2222612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-5-63</ArticleId><ArticleId IdType="pmc">PMC2222612</ArticleId><ArticleId IdType="pubmed">18042300</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al.. Development of a fatigue scale. J Psychosom Res. 1993;37(2):147&#x2013;53. doi: 10.1016/0022-3999(93)90081-p .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(93)90081-p</ArticleId><ArticleId IdType="pubmed">8463991</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SW. Methods for testing statistical differences between groups in medical research: statistical standard and guideline of Life Cycle Committee. Life Cycle. 2022;2:e1. doi: 10.54724/lc.2022.e1</Citation><ArticleIdList><ArticleId IdType="doi">10.54724/lc.2022.e1</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Research Authority. Research involving children 2021 [cited 2022 October 6th,]. Available from: https://www.hra.nhs.uk/planning-and-improving-research/policies-standards-legislation/research-involving-children/</Citation></Reference><Reference><Citation>Keeler. Thoughts about the statistical evaluation of the Borch et al. 2022 data set, Long COVID symptoms and duration in SARS-CoV-2 positive children&#x2014;a nationwide cohort study. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>